Recent Updates
Recently added Catalysts
QGEN Neutral Sentiment Score: 60/100

QIAGEN N.V. to release results for Q3 2024 and hold webcast

Key Takeaway: QIAGEN N.V. has announced that it will release its financial results for the third quarter of 2024 on November 6, shortly after the end of trading. A conference call will take place the following day, November 7, to discuss the results with analysts and investors. The company provides innovative solutions for molecular insights, catering to over 500,000 customers globally across various sectors, including healthcare and life sciences.

Market Sentiment Analysis

Full Press Release Details

Venlo, The Netherlands, Oct. 10, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the third quarter 2024.
Press release date / time: Wednesday, November 6, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time.
Conference call date / time: Thursday, November 7, at 15:30 Frankfurt time / 14:30 London time / 09:30 New York time.
Three options for joining the conference call
Register for call back connection - Click here: Connect me
Service is available 15 minutes before the call starts
U.S.: +1 929 477 0448
UK: +44 (0)330 165 3655
GER: +49 (0)69 6610 2492
Conference ID: 8002609
To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.
Access the audio webcast - Click here:  Access Webcast
A conference call replay will be available by using the following link:
Contact: IR@qiagen.com
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of June 30, 2024, QIAGEN employed more than 5,900 people in over 35 locations worldwide. Further information can be found at https://www.qiagen.com.

Contact Data

Contact

With a Reader Account, it's easy to send email directly to the contact for this release. Sign up today for your free Reader Account!
Already have an account? Log in here.

Frequently Asked Questions

When will QIAGEN release its Q3 2024 results?

QIAGEN plans to release its Q3 2024 results on November 6, 2024.

What time is the QIAGEN conference call scheduled?

The conference call is set for November 7, 2024, at 15:30 Frankfurt time.

How can I join the QIAGEN conference call?

You can join by registering for a callback or accessing the audio webcast.

What is QIAGEN known for?

QIAGEN is a leading provider of Sample to Insight solutions for molecular insights.

How many employees does QIAGEN have?

As of June 30, 2024, QIAGEN employed over 5,900 people globally.

Last updated: Oct 10, 2024